Carsten Boess
Director at Rocket Pharmaceuticals, Inc. (RCKT)
Carsten Boess has filed 13 insider reports with the SEC since June 2021, as director at Rocket Pharmaceuticals, Inc. (RCKT), director at Avidity Biosciences, Inc. (RNAM) and director at Avidity Biosciences, Inc. (RNA) and at 1 more company. The latest filing, on July 7, 2026, reports grant or award at Rocket Pharmaceuticals, Inc. (RCKT).
- Filings
- 13
- Companies
- 4
- Bought on market
- None
- Sold on market
- None
Companies where Carsten Boess is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 52,862 | $2.11 | Jul 7, 2026 | ||||
| Director | 0 | Feb 27, 2026 | |||||
| Director | 6,692 | $6.98 | Jun 12, 2025 | ||||
| Director | Feb 6, 2025 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 18, 2026RCKTDirector Boess Carsten was granted 22,862 shares, increasing direct ownership by 76% to 52,862 unitsForm 4Grant or award
- Feb 27, 2026RNAMDirector Boess Carsten returned 6,692 shares to the company, closing all direct ownership in the companyForm 4Sale back to the company
- Jun 18, 2025RCKTDirector Boess Carsten was granted 30,000 sharesForm 4Grant or award
- Jun 10, 2025RNADirector Boess Carsten was granted 6,692 sharesForm 4Grant or award
- Feb 5, 2025~$34KACHLCarsten Boess plans to sell 25,000 shares (~$34K)Form 144Planned sale
- Jun 13, 2024RCKTSEC Form 4 filed by Director Boess CarstenForm 4Grant or award
- Jun 13, 2024RNASEC Form 4 filed by Director Boess CarstenForm 4Grant or award
- Jun 22, 2023RCKTSEC Form 4 filed by Boess CarstenForm 4Grant or award
- Jun 15, 2023RNASEC Form 4 filed by Boess CarstenForm 4Grant or award
- Jun 15, 2022RNASEC Form 4 filed by Boess CarstenForm 4Grant or award
- Jun 13, 2022RCKTSEC Form 4 filed by Boess CarstenForm 4Grant or award
- Jun 14, 2021RCKTSEC Form 4 filed by BOESS CARSTENForm 4Grant or award
- Jun 16, 2021RNASEC Form 4 filed by BOESS CARSTENForm 4Grant or award
Also sits on boards with
Officers and directors who share two or more companies with Carsten Boess.
- Steven George Hughes2 shared: RNA, RNAM
- Sarah Boyce2 shared: RNA, RNAM
- W. Michael Flanagan2 shared: RNA, RNAM
- Kathleen P. Gallagher2 shared: RNA, RNAM
- Roderick Wong2 shared: RCKT, RNA
- Teresa McCarthy2 shared: RNAM, RNA
- Tamar Thompson2 shared: RNAM, RNA
- Michael F MacLean2 shared: RNAM, RNA
- Simona Skerjanec2 shared: RNAM, RNA
- John B Moriarty2 shared: RNAM, RNA
- Troy Edward Wilson2 shared: RNAM, RNA
- Noreen Henig2 shared: RNAM, RNA
Compare Carsten Boess with
- Carsten Boess vs Steven George Hughes2 shared
- Carsten Boess vs Sarah Boyce2 shared
- Carsten Boess vs W. Michael Flanagan2 shared
- Carsten Boess vs Kathleen P. Gallagher2 shared
- Carsten Boess vs Roderick Wong2 shared
- Carsten Boess vs Teresa McCarthy2 shared
Other insiders at the same companies
- Gaurav ShahRCKT
- Martin WilsonRCKT
- Sarbani ChaudhuriRCKT
- Husam YounisRNA
- Stephanie KenneyRNA
- Brendan R. WinslowRNA
- Rocio Martin HoyosRNA
- Christopher James StevensRCKT
- David P SouthwellRCKT
- Joseph ManhedeRCKT
- Mikael DolstenRCKT
- Fady Ibraham MalikRCKT
Questions about Carsten Boess
- What is Carsten Boess's role at Rocket Pharmaceuticals, Inc.?
- Carsten Boess reports to the SEC as director at Rocket Pharmaceuticals, Inc. (RCKT), according to the latest filing on July 7, 2026. Carsten Boess has also filed as director at Avidity Biosciences, Inc. (RNAM), director at Avidity Biosciences, Inc. (RNA) and director at Achilles Therapeutics plc (ACHL).
- How many shares does Carsten Boess own?
- After the latest filing that states it, Carsten Boess directly owned 52,862 shares of Rocket Pharmaceuticals, Inc. (RCKT) and 6,692 shares of Avidity Biosciences, Inc. (RNA). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Carsten Boess bought or sold stock recently?
- No open-market purchases or sales by Carsten Boess are on file. The filings report grant or award and sale back to the company.
- How do I get alerts when Carsten Boess files?
- Follow Carsten Boess on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Carsten Boess (SEC CIK 0001277495). Totals count each trade once, skipping amendments whose original is on file, from Jun 17, 2021 on. View on SEC EDGAR · Get this as JSON